Company Overview and News

 
SoftBank Group's (SFTBF) CEO Masayoshi Son on Q4 2017 Results - Earnings Call Transcript

2018-05-10 seekingalpha
Thank you very much for waiting, ladies and gentlemen. Now, we would like to start the SoftBank Group Corp earnings results announcement for the fiscal year ended March 31, 2018. First of all, I would like to introduce today's participants. On the front row from left, we have Masayoshi Son, Chairman and CEO; Ken Miyauchi, Director; Yoshimitsu Goto, our Senior Executive Corporate Officer and CFO. At the back row from left, we have Ms.

14
Investing In Colombia In 2018

2018-01-03 seekingalpha
Sometimes you want to manage your international exposure at the country level rather than by regions or classes like "emerging markets."

 
Avianca Airlines, shareholder agree to withdraw lawsuits

2017-11-29 reuters
Nov 29 (Reuters) - Avianca Holdings and a shareholder agreed to withdraw their lawsuits that were filed following disagreements over a planned partnership with U.S. carrier United Airlines, the Colombian airline said on Wednesday.

 
Featured Company News - Avianca Reported August 2017 Traffic Update; Observed a 7.7% Surge in Net Revenue Passenger Kilometers

2017-09-14 accesswire
LONDON, UK / ACCESSWIRE / September 14, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Avianca Holdings S.A. (NYSE: AVH) ("Avianca"), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=AVH. The Company announced on September 11, 2017, its traffic update for August 2017. The Company reported a 4% increase in the number of passengers transported in August 2017 over August 2016.

 
UPDATE 2-Avianca Airlines' No.2 shareholder files injunction to halt United deal

2017-03-15 reuters
March 15 A minority shareholder in Colombian airline Avianca filed a motion for a preliminary injunction Wednesday seeking to halt a deal between the airline's controlling shareholder Synergy Group Corp and United Continental Holdings Inc.

 
As Avianca Weighs Bids, Hedge Fund Plays Unusual Role: Diplomat - The New York Times

2016-12-06 nytimes
Tight on cash, the airline needed to raise money. For many on the board, one option was selling part of the company.

 
Avianca looks to start operating in Argentina

2016-12-05 reuters
BUENOS AIRES Dec 5 Avianca Holdings SA, one of Latin America's largest airlines, has requested approval to operate domestic and international flights in Argentina, the country's government said on Monday.

 
The MRO Implications Of Synergy Group’s Pan-Latin America Airline Ambitions

2016-11-18 aviationweek
Not content with opening in September what is probably Latin America’s most impressive MRO facility, the new Avianca Aeronautical Center in Rionegro near Medellin, Avianca’s parent Synergy Group has made two moves this week which show that it is positioning itself as the only airline group with the ambition to be omnipresent throughout Latin America.

 
Final Results

2016-03-16 londonstockexchange
Tribal, a leading provider of software and services for education management, announces its financial results for the year ended 31 December 2015.

 
The Synergy Company™ introduces its patent-pending, certified organic SuperPure® Turmeric Extract

2016-03-01 prnewswire
MOAB, Utah, March 1, 2016 /PRNewswire/ -- The Synergy Company™, a privately and family-owned nutritional...

 
Proposed acquisition of Synergy from Tribal Group

2016-03-01 londonstockexchange
Servelec, the UK-headquartered technology group, is pleased to announce that it has conditionally agreed to acquire the Synergy business ("Synergy") from Tribal Education Limited a wholly-owned subsidiary of Tribal Group plc ("Tribal" or the "Seller") for a consideration of £20.25 million (the "Acquisition") in cash on completion. The Acquisition is a Class 1 transaction for the Seller under the Listing Rules and is therefore conditional, inter alia, upon Tribal attainting approval for the disposal from its Shareholders.

 
Disposal

2016-03-01 londonstockexchange
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 
Red River College earns national award for sustainability work

2016-02-16 winnipegfreepress
Red River College's work with Manitoba Hydro on sustainable infrastructure has earned it a national award. The college, in partnership with Manitoba Hydro, has been awarded Canada’s top honour from the Natural Sciences and Engineering Research Council (NSERC).

 
Federal Way Public Schools Implements Edupoint's Learning Management Solution

2016-02-10 prnewswire
MESA, Ariz., Feb. 9, 2016 /PRNewswire/ -- Edupoint® Educational Systems – a leading student...

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...